Blood Amyloid-β Reduction Following Chongnoi-tang Treatment in Alzheimer’s Spectrum Conditions: A Retrospective Pilot Observational Study
Background/Objectives: Anti-amyloid immunotherapies reduce amyloid-β (Aβ) plaques but carry a 15–35% risk of amyloid-related imaging abnormalities (ARIA), particularly in APOE ε4/ε4 carriers. This preliminary observational study evaluated blood Aβ oligomer changes following treatment with the multi-component herbal for...